Effect of race/ethnicity on arterial recanalization following intravenous thrombolysis in acute ischemic stroke patients.
暂无分享,去创建一个
A. Qureshi | F. Siddiq | Camilo R Gomez | Brandi R. French | R. Fakih | Xiaoyun Ma | Navpreet K. Bains | Camilo R. Gomez | A. Lodhi | B. French
[1] Hester F. Lingsma,et al. Benefit of successful reperfusion achieved by endovascular thrombectomy for patients with ischemic stroke and moderate pre-stroke disability (mRS 3): results from the MR CLEAN Registry , 2022, Journal of NeuroInterventional Surgery.
[2] Eric E. Smith,et al. Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke , 2022, Neurology.
[3] Rizwan Kalani,et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association , 2022, Circulation.
[4] T. Tatlisumak,et al. Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry , 2021, Journal of Neurology.
[5] W. Heindel,et al. Histological Clot Composition Is Associated With Preinterventional Clot Migration in Acute Stroke Patients. , 2019, Stroke.
[6] J. Broderick,et al. Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial , 2016, Interventional Neurology.
[7] Michael D Hill,et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial , 2014, The Lancet Neurology.
[8] Michael D Hill,et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. , 2013, The New England journal of medicine.
[9] H. Cloft,et al. Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[10] R. Gillum,et al. Ethnic and Geographic Variation in Stroke Mortality Trends , 2011, Stroke.
[11] W. Rosamond,et al. Racial-Ethnic Disparities in Stroke Care: The American Experience A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[12] A. Demchuk,et al. Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action , 2010, Stroke.
[13] Eric E. Smith,et al. Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke , 2010, Circulation.
[14] Zsolt Garami,et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.
[15] R. Sacco,et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. , 2006, Stroke.
[16] E. Emanuel,et al. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? , 2005, PLoS medicine.
[17] A. Alexandrov,et al. Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions , 2018, Stroke.
[18] J. Gerberding,et al. Disparities in deaths from stroke among persons aged <75 years--United States, 2002. , 2005, MMWR. Morbidity and mortality weekly report.
[19] J. Kostis,et al. Delay in presentation and evaluation for acute stroke : Stroke time registry for outcomes knowledge and epidemiology (S. T. R. O. K. E.) , 2001 .